市場調查報告書
商品編碼
1576661
連續血糖監測市場規模、佔有率、預測、趨勢分析:按組件(感測器[一次性、植入式]、接收器、發射器)、按年齡組(成人、兒童)、按最終用戶(家庭護理、醫院和診所)-世界預計到 2031 年Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics) - Global Forecast to 2031 |
預計到 2031 年,全球連續血糖監測市場將達到 314.1 億美元,2024 年至 2031 年複合年增長率為 15%。
經過廣泛的二次和初步研究以及對市場情景的詳細分析,本報告對關鍵行業驅動因素、限制因素、課題和機會進行了分析。連續血糖監測(CGM)市場的成長是由人們生活方式的變化、糖尿病等慢性病負擔的增加、CGM相對於傳統血糖監測的優勢以及運動員和運動員對CGM不斷增長的需求推動的。帶動。然而,CGM 設備的高成本和產品召回限制了該市場的成長。
此外,CGM 設備的技術進步、個人化護理的轉變、健康意識的提高以及新興國家糖尿病護理設備的可及性的提高預計將為市場增長創造機會。然而,大量未確診的糖尿病患者以及與 CGM 設備的黏附性、可靠性和準確性相關的問題是全球連續血糖監測市場的主要課題。
(註:提供上位5公司的SWOT分析)
Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics)-Global Forecast to 2031
The global continuous glucose monitoring market is projected to reach $31.41 billion by 2031 at a CAGR of 15% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the continuous glucose monitoring (CGM) market is driven by lifestyle changes among the population coupled with the growing burden of chronic conditions such as diabetes, the benefits offered by CGM over conventional glucose monitoring, and the use of CGM by athletes and fitness enthusiasts. However, high costs and product recalls of CGM devices restrain the growth of this market.
Furthermore, technological advancements in CGM devices, a shift toward personalized care and, rising health awareness, and increasing accessibility for diabetes care devices in developing countries are expected to generate market growth opportunities. However, the high number of people living undiagnosed with diabetes patients and problems related to the adhesiveness, reliability, and accuracy of CGM devices are major challenges in the global continuous glucose monitoring market.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the continuous glucose monitoring market are DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum. Technologies, Inc. (Shanghai.), and B. Braun SE (Germany).
Among all the components studied in this report, in 2024, the sensors segment is expected to account for the largest share of 52.4% of the continuous glucose monitoring market. The sensors segment is further segmented into disposable sensors and implantable sensors. The large market segment is attributed to the high demand for continuous glucose monitoring and frequent purchases of sensors compared to receivers and transmitters. Sensors require more frequent replacement compared to other components. Disposable sensors are replaced in 7 to 14 days after placement while implantable sensors can be replaced in 150-180 days.
Among all the age groups studied in this report, in 2024, the adult segment is expected to account for a larger share of the continuous glucose monitoring market. This segment's large market share can be attributed to the high proportion of the geriatric population with diabetes and changing lifestyles leading to diseases such as obesity, depression, anxiety, and cardiovascular diseases.
Among all the end users studied in this report, in 2024, the home care settings segment is expected to account for a larger share of 82.3% of the continuous glucose monitoring market. The large market share of this segment is attributed to factors such as the high prevalence of diabetes worldwide, rising awareness among people, a shift toward preventive healthcare, and easy accessibility to CGM in developed countries. CGM technologies provide numerous advantages in home care settings. There is a growing shift toward home healthcare due to the lack of healthcare professionals and increasing consumer awareness regarding the monitoring of diabetic conditions through CGM, which supports the large market share of the segment.
An in-depth analysis of the geographical scenario of the global continuous glucose monitoring market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 17.4% during the forecast period. The market growth of this region is attributed to the advancing healthcare infrastructure, growing disposable income, and rising investments by major key market players. Furthermore, economic growth, as well as technological developments support the market growth in Asia-Pacific.
Continuous glucose monitoring Market Assessment-by Component
Continuous glucose monitoring Market Assessment-by Age Group
Continuous glucose monitoring Market Assessment-by End User
Continuous glucose monitoring Market Assessment-by Geography
(Note: SWOT Analysis will be Provided for The Top 5 Players)